Zhejiang Orient Gene Biotech Co., Ltd (SHA:688298)

SHA:688298 Revenue

Zhejiang Orient Gene Biotech had revenue of 191.95M CNY in the quarter ending March 31, 2025, with 4.94% growth. This brings the company's revenue in the last twelve months to 835.74M, up 33.28% year-over-year. In the year 2024, Zhejiang Orient Gene Biotech had annual revenue of 826.71M with 0.80% growth.

• Revenue (ttm): 835.74M
• Revenue Growth: +33.28%
• P/S Ratio: 5.37
• Revenue / Employee: 374.60K
• Employees: 2,231
• Market Cap: 4.49B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	826.71M	6.55M	0.80%
Dec 31, 2023	820.16M	-7.95B	-90.65%
Dec 31, 2022	8.77B	-1.40B	-13.78%
Dec 31, 2021	10.17B	6.90B	211.43%
Dec 31, 2020	3.27B	2.90B	788.83%